The star of the acquisition, anti-IgE antibody ozureprubart, is being tested as a prophylactic treatment for food allergies, ...
That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...
Findings showed that compared with placebo, Xolair significantly increased the amount of peanut, milk, egg, and cashew participants could consume without an allergic reaction. The Food and Drug ...
Xolair, an antibody asthma drug, was recently approved for severe food allergic reactions. It is not the first biological drug to treat multiple conditions. But it is the first to treat severe food ...
Xolair is widely available and can now be prescribed for appropriate patients with IgE-mediated food allergy in the US. "Many people with food allergies and their loved ones live in constant fear of ...
Basel, 16 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair® (omalizumab) for the reduction of allergic reactions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results